Related Experiment Videos
Evaluation of brain natriuretic peptide in the diagnosis of heart failure
P Bettencourt1, A Ferreira, P Dias
1Serviço de Medicina III, Hospital S. João, Porto, Portugal. pbettfer@esoterica.pt
Insights
Brain natriuretic peptide (BNP) accurately diagnoses heart failure (HF), including isolated diastolic HF. BNP measurement aids in diagnosing HF and guiding further patient evaluation.
Area of Science:
- Cardiology
- Biomarkers
- Diagnostic Medicine
Background:
- Diagnosing heart failure (HF) can be challenging, particularly in patients presenting with subtle symptoms.
- Systolic and diastolic ventricular dysfunction are key components of HF requiring precise diagnostic methods.
Purpose of the Study:
- To assess the diagnostic utility of brain natriuretic peptide (BNP) for identifying heart failure (HF).
- To specifically evaluate BNP's accuracy in diagnosing HF with systolic or isolated diastolic ventricular dysfunction.
Main Methods:
- The study included 100 patients and 9 healthy controls.
- Diagnosis of HF was confirmed using clinical assessments and echocardiographic findings.
- Brain natriuretic peptide (BNP) levels were measured and analyzed using receiver operating characteristic (ROC) curves.
Main Results:
- BNP levels demonstrated high accuracy in diagnosing HF, with an area under the ROC curve (AUC) of 0.92.
- BNP measurement showed excellent accuracy for diagnosing isolated diastolic HF, achieving an AUC of 0.89.
Conclusions:
- BNP measurement is a valuable tool for diagnosing heart failure (HF).
- BNP levels can effectively identify patients with isolated diastolic HF.
- BNP testing assists in selecting patients who require further diagnostic evaluation for HF.
Abstract:
A diagnosis of heart failure (HF) can be difficult, especially in patients with mild symptomatology. The purpose of this study was to evaluate the significance of brain natriuretic peptide (BNP) in the diagnosis of HF with systolic or isolated diastolic ventricular dysfunction. One hundred patients and 9 controls were included in the study. Eighty-five patients were diagnosed with HF, based on clinical and echocardiographic findings. BNP levels were accurate for the diagnosis of HF, with an area under the receiver operating characteristic (ROC) curve (AUC) of 0.92. In addition, BNP levels showed an excellent accuracy for the diagnosis of isolated diastolic HF (AUC = 0.89). These data suggest that the measurement of BNP levels may be helpful in the diagnosis of HF and in selecting patients for further evaluation. Furthermore, BNP measurement can play an important role in the diagnosis of isolated diastolic HF.